New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
11:19 EDTDARADara orphan drug could make it takeover target, Triangle Business Journal says
Dara BioSciences shares jumped after the company received orphan drug designation for its experimental cancer pain treatment, which Dara CEO David Drutz said "creates a lot of interest" for potential U.S. partners, according to Triangle Business Journal. “Some have told us they might be particularly interested if we get the [orphan drug] designation,” the report quotes Drutz as stating. Reference Link
News For DARA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
07:44 EDTDARAAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use